1402559-18-5

Basic information

• Product Name: benzyl N-[4-(3-amino-2-cyano-5,6-dihydro-4H-cyclopenta[b]pyrrol-1-yl)phenyl]carbamate
• Synonyms: benzyl N-[4-(3-amino-2-cyano-5,6-dihydro-4H-cyclopenta[b]pyrrol-1-yl)phenyl]carbamate
• CAS NO: 1402559-18-5
• Molecular Weight: 372.426
• Mol File: 1402559-18-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: benzyl N-[4-(3-amino-2-cyano-5,6-dihydro-4H-cyclopenta[b]pyrrol-1-yl)phenyl]carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl N-[4-(3-amino-2-cyano-5,6-dihydro-4H-cyclopenta[b]pyrrol-1-yl)phenyl]carbamate(1402559-18-5)
• EPA Substance Registry System: benzyl N-[4-(3-amino-2-cyano-5,6-dihydro-4H-cyclopenta[b]pyrrol-1-yl)phenyl]carbamate(1402559-18-5)

Safety Data

• Hazardous Substances Data: 1402559-18-5(Hazardous Substances Data)

Upstream product

• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 2941-29-9 2-oxocyclopentanecarbonitrile 
• 111-69-3 hexanedinitrile 
• 1402559-16-3 benzyl N-[4-(cyanomethylamino)phenyl]carbamate 
• 1402559-17-4 benzyl N-[4-[(2-cyanocyclopenten-1-yl)(cyanomethyl)amino]phenyl]carbamate 
• 82720-42-1 (4-Amino-phenyl)-carbamic acid benzyl ester 
• 501-53-1 benzyl chloroformate 
• 106-50-3 1,4-phenylenediamine 

Downstream Products

• 1402558-20-6 benzyl N-[4-(4-amino-7,8-dihydro-6H-cyclopenta[2,3]pyrrolo[2,4-d]pyrimidin-5-yl)phenyl]carbamate 
• 1402558-21-7 5-(4-aminophenyl)-7,8-dihydro-6H-cyclopenta[2,3]pyrrolo[2,4-d]pyrimidin-4-amine 
• 1402558-22-8 C₂₁H₁₉N₅O₂S 
• 1402558-37-5 C₂₃H₁₉F₃N₆O 

Relevant articles and documents

COMPOUNDS USEFUL AS CSF1 MODULATORS

This invention relates to novel compounds and to pharmaceutical compositions comprising the novel compounds. More specifically, the invention relates to compounds useful as Colony Stimulating Factor 1 Receptor (cFMS) modulators (e.g. cFMS inhibitors). This invention also relates to processes for preparing the compounds, uses of the compounds in treatment and methods of treatment employing the compounds. Specifically, the invention relates to the use of the compounds for the treatment of cancer and autoimmune diseases.